4.0 Article

Association of the CD226 Ser307 Variant With Systemic Sclerosis Evidence of a Contribution of Costimulation Pathways in Systemic Sclerosis Pathogenesis

期刊

ARTHRITIS AND RHEUMATISM
卷 63, 期 4, 页码 1097-1105

出版社

WILEY
DOI: 10.1002/art.30204

关键词

-

资金

  1. Agence Nationale de la Recherche [R070994KS]
  2. Societe Francaise de Rhumatologie
  3. Association des Sclerodermiques de France
  4. Groupe Francais de Recherche sur la Sclerodermie
  5. INSERM
  6. Swiss National Science Foundation [31003A_124941/1]
  7. German Federal Ministry for Education and Research [01 GM 0310, 01 GM 0634]
  8. Actelion
  9. Pfizer
  10. Lilly
  11. GlaxoSmithKline
  12. Swiss National Science Foundation (SNF) [31003A_124941] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Objective. The nonsynonymous polymorphism rs763361 of the CD226 gene, which encodes DNAX accessory molecule 1, which is involved in T cell co-stimulation pathways, has recently been identified as a genetic risk factor for autoimmunity. The purpose of this study was to test for association of the CD226 rs763361 polymorphism with systemic sclerosis (SSc) in European Caucasian populations. Methods. CD226 rs763361 was genotyped in 3,632 individuals, consisting of a discovery sample (991 SSc patients and 1,008 controls) and a replication sample (999 SSc patients and 634 controls). All study subjects were of European Caucasian origin. Expression of CD226 was assessed on peripheral blood mononuclear cells obtained from 21 healthy donors genotyped for CD226 rs763361. Results. The CD226 rs763361 T allele was found to be associated with SSc in both the discovery and the replication samples, showing the following results in the combined populations: odds ratio (OR) 1.22 (95% confidence interval [95% CI] 1.10-1.34), P = 5.69 x 10(-5). The CD226 T allele was also associated with various SSc subsets, highlighting a potential contribution to disease severity. The most remarkable associations of the CD226 TT risk genotype were observed with the diffuse cutaneous SSc subtype, the anti-topoisomerase I antibody-positive, and SSc-related fibrosing alveolitis subsets: OR 1.86 (95% CI 1.42-2.43), P = 5.15 x 10(-6), OR 1.82 (95% CI 1.38-2.40), P = 2.16 x 10(-5), and OR 1.61 (95% CI 1.25-2.08), P = 2.73 x 10(-4), respectively. CD226 expression was not significantly influenced by CD226 rs763361 genotypes whatever the T cell subtype investigated. Conclusion. Our results establish CD226 as a new SSc genetic susceptibility factor underlying the contribution of costimulation pathways in the pathogenesis of SSc. Further work is nevertheless needed to define the causal variant at the CD226 locus as well as the functional consequences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization

Claudia Ferlito, Vincenzo Visco, Roberto Biselli, Maria Sofia Cattaruzza, Giulia Carreras, Gerardo Salerno, Florigio Lista, Maria Rosaria Capobianchi, Concetta Castilletti, Daniele Lapa, Guido Antonelli, Massimo Gentile, Maurizio Sorice, Gloria Riitano, Giuseppe Lucania, Valeria Riccieri, Fabrizio Mainiero, Antonio Angeloni, Marco Lucarelli, Giampiero Ferraguti, Alberto Autore, Marco Lastilla, Simonetta Salemi, Michela Ileen Biondo, Andrea Picchianti-Diamanti, Sara Caporuscio, Raffaela Teloni, Sabrina Mariotti, Roberto Nisini, Raffaele D'Amelio

Summary: This study analyzed the possible late appearance of side effects and the half-life of induced antibodies in a military cohort. The results showed no late side effects and confirmed the long duration of certain vaccine-induced antibodies.

BIOMEDICINES (2022)

Article Rheumatology

Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort

Michael Hughes, Suiyuan Huang, Juan Jose Alegre-Sancho, Patricia E. Carreira, Merete Engelhart, Eric Hachulla, Joerg Henes, Eduardo Kerzberg, Maria Rosa Pozzi, Gabriela Riemekasten, Vanessa Smith, Gabriella Szucs, Marie Vanthuyne, Elisabetta Zanatta, Oliver Distler, Armando G. Gabrielli, Anna-Maria Hoffmann-Vold, Virginia D. Steen, Dinesh Khanna

Summary: This study aimed to investigate the prevalence and characteristics of late skin fibrosis in systemic sclerosis (SSc). The study found that late skin fibrosis is not uncommon in SSc, and different patterns of development exist among patients. Patients with lower baseline mRSS and lcSSc are more likely to develop late skin fibrosis. Anti-Scl-70 is associated with progression from lcSSc to dcSSc, while anticentromere antibodies have a protective effect.

RHEUMATOLOGY (2023)

Review Medicine, General & Internal

Genetic and molecular architecture of familial hypercholesterolemia

Marianne Abifadel, Catherine Boileau

Summary: Atherosclerotic cardiovascular disease is a major cause of death worldwide, and familial hypercholesterolemia (FH) is a commonly inherited disease with significant risks. Advances in genetic research have greatly improved the diagnosis and treatment of FH, providing more therapeutic options.

JOURNAL OF INTERNAL MEDICINE (2023)

Article Rheumatology

Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases

Yann Nguyen, Cecile M. Yelnik, Nathalie Morel, Romain Paule, Romain Stammler, Leo Placais, Karim Sacre, Bertrand Godeau, Helene Maillard, David Launay, Sandrine Morell-Dubois, Anastasia Dupre, Guillaume Lefevre, Cecile Devloo, Virginie Dufrost, Ygal Benhamou, Herve Levesque, Gaelle Leroux, Jean-Charles Piette, Luc Mouthon, Eric Hachulla, Marc Lambert, Veronique Le Guern, Nathalie Costedoat-Chalumeau

Summary: This study used unsupervised clustering analysis to identify four homogeneous phenotypic subgroups among APS patients, primarily involving venous, arterial, SLE or other autoimmune disease-associated, and arterial microthrombotic phenotypes. These findings may be explained by heterogeneous pathophysiological mechanisms.

RHEUMATOLOGY (2023)

Article Rheumatology

Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

Michele Iudici, Denis Mongin, Elise Siegert, Patricia E. Carreira, Joerg Distler, Joerg Henes, Elisabetta Zanatta, Eric Hachulla, Giacomo De Luca, Carolina de Souza Mueller, Tania Santiago, Jose-Luis Tandaipan, Breno Valdetaro Bianchi, Maria De Santis, Anna-Maria Hoffmann-Vold, Armando Gabrielli, Oliver Distler, Delphine Sophie Courvoisier

Summary: The study aimed to estimate the prevalence of long-term exposure to glucocorticoids (GCs) among SSc patients and identify factors associated with prescribing practices over time and across countries. The results showed that the utilization of GCs is widespread and long-term in SSc patients, with significant variations between countries and within-country. However, there has been a gradual decrease in their utilization.

RHEUMATOLOGY (2023)

Article Rheumatology

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Alain Lescoat, Doerte Huscher, Nils Schoof, Paolo Airo, Jeska De Vries-Bouwstra, Gabriela Riemekasten, Eric Hachulla, Andrea Doria, Edoardo Rosato, Nicolas Hunzelmann, Carlomaurizio Montecucco, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler, Jennifer Ben Shimol, Maurizio Cutolo, Yannick Allanore

Summary: The prevalence and characteristics of SSc-associated interstitial lung disease (SSc-ILD) vary between geographical regions. This study aimed to explore the differences in prevalence, phenotype, treatment, and prognosis in patients with SSc-ILD from different regions in the EUSTAR database. The results showed significant variations in clinical characteristics, survival rates, and treatment approaches among different regions.

RHEUMATOLOGY (2023)

Article Rheumatology

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis

Sebastien Sanges, Lisa Rice, Ly Tu, Eleanor Valenzi, Jean-Luc Cracowski, David Montani, Julio C. Mantero, Camille Ternynck, Guillemette Marot, Andreea M. Bujor, Eric Hachulla, David Launay, Marc Humbert, Christophe Guignabert, Robert Lafyatis

Summary: This study examined the serum proteome of patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) and identified two proteins that were significantly correlated with pulmonary vascular resistance (PVR), potentially providing biomarkers for earlier diagnosis and treatment.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort

Amalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, Antonella Romaniello, Armando Gabrielli, Eric Hachulla, Vanessa Smith, Carmen-Pilar Simeon-Aznar, Ivan Castellvi, Paolo Airo, Marie-Elise Truchetet, Elise Siegert, Oliver Distler, Edoardo Rosato

Summary: This study evaluated the predictive role of the echocardiography-derived TAPSE/sPAP ratio for pulmonary hypertension (PH) diagnosis and mortality. The study found that a TAPSE/sPAP ratio < 0.55 mm/mmHg is a predictive risk factor for PH, and a TAPSE/sPAP ratio <= 0.32 mm/mmHg is a predictive risk marker for all-cause mortality.

AUTOIMMUNITY REVIEWS (2023)

Article Immunology

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection

Cloe Comarmond, Elodie Drumez, Julien Labreuche, Eric Hachulla, Thierry Thomas, Rene-Marc Flipo, Raphaelle Seror, Jerome Avouac, Nathalie Balandraud, Renaud Desbarbieux, Renaud Felten, Melanie Gilson, Marie-Hlene Guyot, Ambre Hittinger-Roux, Thao Pham, Myriam Renard, Nicolas Roux, Vincent Sobanski, Anne Tournadre, Christophe Richez, Patrice Cacoub

Summary: This study investigated whether RMD patients receiving anti-IL6 therapy have less severe forms of COVID-19 and better outcomes. Retrospective analysis of the French RMD COVID-19 cohort data showed that the severity of COVID-19 was lower in the anti-IL6 group, but there were no significant differences in the evolution of COVID-19 between the groups.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2023)

Article Rheumatology

Points to consider: EULAR-UEMS standards for the training of European rheumatologists

Alessia Alunno, Tadej Avcin, Catherine Haines, Sofia Ramiro, Francisca Sivera, Sara Badreh, Xenofon Baraliakos, Johannes W. J. Bijlsma, Frank Buttgereit, Kaushik Chaudhuri, Jose A. P. Da Silva, Jean Dudler, Ricardo J. O. Ferreira, Tania Gudu, Eric Hachulla, Mette Holland-Fischer, Annamaria Iagnocco, Tue Wenzel Kragstrup, Gyoergy Nagy, Vasco C. Romao, Simon R. Stones, Marloes van Onna, Christopher J. Edwards

Summary: This study aimed to define competences and standards for the training of rheumatologists. Through collaboration and analysis of international training documents, an overall framework, 7 domains, 8 core themes, and 28 competences were established. The results suggest that these standards can contribute to harmonizing rheumatology training across European countries.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Respiratory System

NKX2.1 mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis

Pierre Le Guen, Raphael Borie, Marie Legendre, Clairelyne Dupin, Laetitia Dunogeant, Sebastien Ottaviani, Marie-Pierre Debray, Aurelie Cazes, Philippe Dieude, Caroline Kannengiesser, Bruno Crestani

ERJ OPEN RESEARCH (2023)

Review Rheumatology

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review

Eric L. L. Matteson, Marco Matucci-Cerinic, Michael Kreuter, Gerd R. Burmester, Philippe Dieude, Paul Emery, Yannick Allanore, Janet Pope, Dinesh Khanna

Summary: By studying patient-level factors in patients with rheumatoid arthritis (RA), it was found that there were consistent associations between age, sex, smoking status, and autoantibodies and the development of interstitial lung disease (ILD). These findings provide a basis for future research and contribute to a better understanding and management of the risk of ILD development and progression in patients with RA.

RMD OPEN (2023)

Article Rheumatology

Systemic sclerosis associated interstitial lung disease: a survey of current practices in France

Amelie Nicolas, Sylvie Leroy, Luc Mouthon, Yurdagul Uzunhan, Vincent Cottin, Arsene Mekinian, Viviane Queyrel, Eric Hachulla, Benoit Gachet, David Launay, Nihal Martis

Summary: This study provides an overview of the diagnostic approaches, follow-up, and treatment strategies used in France for the management of SSc-associated ILD. The results highlight the heterogeneity and gaps in current clinical practices, calling for improvement and standardization.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Meeting Abstract Rheumatology

EPIDEMIOLOGY OF IDIOPATHIC INFLAMMATORY MYOPATHIES IN AFRICA: A CONTEMPORARY SYSTEMATIC REVIEW

Mickael Essouma, Jean Jacques Noubiap, Madeleine Singwe-Ngandeu, Eric Hachulla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

MUSCLE INVOLVEMENT IN SYSTEMIC SCLEROSIS: REVISITING THE CLASSIFICATION IN LIGHT OF AUTOMATED MORPHOMETRY

Louai Zaidan, Noemie Le Gouellec, Eric Hachulla, Luc Mouthon, Francois Jerome Authier

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

暂无数据